Telehealth

A new long-term deal for the INTERCEPT system highlights a critical shift towards proactive pathogen reduction to protect France's blood supply from global threats.

Medicana Health Group aims for 25,000 HPV shots annually, stepping into a major public health gap. But can this private initiative overcome cost barriers?

A landmark $41M donation from the Weston family to Sunnybrook aims to overhaul Canada's clinical trial landscape, promising faster patient access to therapies.

As federal marijuana reclassification opens new doors, a company named Dogecoin Cash is leveraging its telehealth platform to capitalize on the change.

A revolutionary organ preservation system is showing 100% graft survival in new studies, promising to expand the donor pool for children in need.

In a landmark decision, the DEA has rescheduled medical cannabis, unlocking scientific research, slashing industry taxes, and reshaping patient access.

A novel RNA vaccine targeting hidden cancer antigens gets UK approval for a clinical trial, offering new hope for patients with hard-to-treat ovarian cancer.

As Materialise preps its Q1 2026 report, all eyes are on its booming medical unit to see if it can offset persistent industrial market weakness.

A breakthrough review validates harnessing neutrophils, the immune system's foot soldiers, for cancer, with a new therapy now heading to human trials.

As cyberattacks and IT failures plague hospitals, a new BICSI standard offers a blueprint for building resilient ICT infrastructure to protect patient safety.

A novel, minimally invasive nerve ablation technology shows long-term promise for relieving severe pancreatic cancer pain, a major unmet medical need.

A new survey reveals a major shift in health IT, with managed services now central to strategy, but urban and rural hospitals are taking different paths.

A new powerhouse residency program backed by Silicon Valley elite launches near Stanford to turn academic science into fundable healthcare companies.

A record-breaking medical conference reveals a major shift in medicine, as practitioners move from simply managing aging to pursuing biological age reversal.

ProRx Pharma touts a major expansion to meet drug demand, but recent FDA warnings and massive recalls raise serious questions about its quality and safety.

A new AI tool is automating healthcare's most hated paperwork, getting patients on complex drugs in 48 hours and giving doctors back their time.

The medtech giant posts Q1 growth and secures critical EU approvals for new devices, navigating post-pandemic shifts and geopolitical headwinds with strong cash flow.

Oscar Health launches Lucie, an AI-powered marketplace promising to give consumers unprecedented choice and control over their health insurance plans.

The Spanish airline is the first in the country to deploy an advanced medical ecosystem, giving passengers access to a virtual doctor at 30,000 feet.

The new CMS Medicare App Library is giving millions of seniors access to AI-driven health tools, but can technology bridge the gap in patient care?